Developing pipette-free tools to screen 3D cell models in multiwell plates
Patient biopsies are scarce, and stem cells can be costly, limiting the material available for screening experiments. Cancer researchers need efficient, scalable ways to screen these samples in three-dimensional cell cultures for drug discovery and genetic analysis.
AssureDrop is developing a pipette-free platform that screens organoids in tiny droplets within multiwell plates. Designed to fit existing lab workflows, it aims to help researchers test more drug conditions using limited patient-derived samples.
What stands out about AssureDrop
The v1 platform successfully micro-dispensed cells in an external laboratory.
Founder reports multiple letters of intent across academia and industry.
Selected for Discovery Park's oncology-focused Discovery Spark business development cohort in 2025.
Ankur Chaurasia conducted doctoral microfluidics research at King's College London and later developed spheroid-screening systems.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.